Keenova Therapeutics plc
NONE
32 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 22 12:59 AM | Silver Point Capital L.P.10% Owner | Purchase | 210,000 | $90.50 | $19.0M | 6,035,214(D) | View → |
| May 19, 2026 | May 22 12:59 AM | Silver Point Capital L.P.10% Owner | Purchase | 187,500 | $90.50 | $17.0M | 5,825,214(D) | View → |
| Apr 17, 2026 | Apr 17 9:23 PM | Silver Point Capital L.P.10% Owner | Purchase | 410,000 | $90.50 | $37.1M | 5,637,714(D) | View → |
| Apr 15, 2026 | Apr 17 9:23 PM | Silver Point Capital L.P.10% Owner | Purchase | 275,000 | $88.50 | $24.3M | 5,227,714(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 4 8:14 PM | Sophia J. LangloisDirector | Option Exercise | 2,685 | — | 3,984(D) | View → |
| Jun 2, 2026 | Jun 4 8:14 PM | Sophia J. LangloisDirector | Disposition | 2,197 | — | 6,669(D) | View → |
| Jun 2, 2026 | Jun 4 8:13 PM | Scott HirschDirector | Option Exercise | 2,685 | — | 3,984(D) | View → |
| Jun 2, 2026 | Jun 4 8:13 PM | Scott HirschDirector | Disposition | 2,197 | — | 6,669(D) | View → |
| Jun 2, 2026 | Jun 4 8:12 PM | Paul EfronDirector | Disposition | 2,930 | — | 7,564(D) | View → |
| Jun 2, 2026 | Jun 4 8:12 PM | Paul EfronDirector | Option Exercise | 3,580 | — | 3,984(D) | View → |
| Jun 2, 2026 | Jun 4 8:12 PM | Katina DortonDirector | Option Exercise | 4,882 | — | 27,000(D) | View → |
| Jun 2, 2026 | Jun 4 8:11 PM | Leslie E DonatoDirector | Option Exercise | 4,882 | — | 3,984(D) | View → |
| Jun 2, 2026 | Jun 4 8:11 PM | Paul BisaroDirector | Disposition | 2,197 | — | 45,028(D) | View → |
| Jun 2, 2026 | Jun 4 8:11 PM | Paul BisaroDirector | Option Exercise | 2,685 | — | 42,343(D) | View → |
| Jun 2, 2026 | Jun 4 8:10 PM | Jon ZinmanDirector | Option Exercise | 4,882 | — | 34,672(D) | View → |
| Jun 2, 2026 | Jun 4 8:10 PM | Marc J YoskowitzDirector | Disposition | 2,930 | — | 8,891(D) | View → |
| Jun 2, 2026 | Jun 4 8:10 PM | Marc J YoskowitzDirector | Option Exercise | 3,579 | — | 5,312(D) | View → |
| Apr 23, 2026 | Apr 25 12:02 AM | Tracy BassoEVP & CHRO | Option Exercise | 1,523 | — | 46,717(D) | View → |
| Apr 23, 2026 | Apr 25 12:00 AM | Cheryl Ann StouchEVP & Chief Info Officer | Option Exercise | 1,137 | — | 25,032(D) | View → |
| Apr 23, 2026 | Apr 25 12:00 AM | Susan Ann WilliamsonEVP & Chief Compliance Officer | Option Exercise | 1,305 | — | 26,378(D) | View → |
| Feb 25, 2026 | Feb 27 2:15 AM | Henriette NielsenEVP & Chief Transformation OFC | Grant/Award | 51,794 | — | 97,825(D) | View → |
| Feb 25, 2026 | Feb 27 2:13 AM | Marek HonczarenkoEVP, Chief Scientific Officer | Grant/Award | 58,434 | — | 58,434(D) | View → |
| Feb 25, 2026 | Feb 27 2:11 AM | Lisa FrenchEVP & Chief Commercial Officer | Grant/Award | 51,794 | — | 97,825(D) | View → |
| Feb 25, 2026 | Feb 27 2:09 AM | Tracy BassoEVP & CHRO | Grant/Award | 34,528 | — | 48,240(D) | View → |
Page 1 of 2
Next →